Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma.
Klemen ND, Hwang S, Bradic M, Rosenbaum E, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Movva S, Thornton KA, Chi P, Nacev BA, Chan JE, Bartlett EK, Richards AL, Singer S, Donoghue MTA, Tap WD, D'Angelo SP. Klemen ND, et al. Among authors: keohan ml. Clin Cancer Res. 2022 Mar 1;28(5):939-947. doi: 10.1158/1078-0432.CCR-21-3445. Clin Cancer Res. 2022. PMID: 34965948 Free PMC article.
Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Gounder MM, Lefkowitz RA, Keohan ML, D'Adamo DR, Hameed M, Antonescu CR, Singer S, Stout K, Ahn L, Maki RG. Gounder MM, et al. Among authors: keohan ml. Clin Cancer Res. 2011 Jun 15;17(12):4082-90. doi: 10.1158/1078-0432.CCR-10-3322. Epub 2011 Mar 29. Clin Cancer Res. 2011. PMID: 21447727 Free PMC article.
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial.
Luke JJ, D'Adamo DR, Dickson MA, Keohan ML, Carvajal RD, Maki RG, de Stanchina E, Musi E, Singer S, Schwartz GK. Luke JJ, et al. Among authors: keohan ml. Clin Cancer Res. 2012 May 1;18(9):2638-47. doi: 10.1158/1078-0432.CCR-11-3203. Epub 2012 Feb 28. Clin Cancer Res. 2012. PMID: 22374332 Free PMC article. Clinical Trial.
Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.
Gerber NK, Wexler LH, Singer S, Alektiar KM, Keohan ML, Shi W, Zhang Z, Wolden S. Gerber NK, et al. Among authors: keohan ml. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):58-63. doi: 10.1016/j.ijrobp.2012.12.016. Epub 2013 Feb 13. Int J Radiat Oncol Biol Phys. 2013. PMID: 23414767 Free PMC article.
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
Dickson MA, Tap WD, Keohan ML, D'Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Dickson MA, et al. Among authors: keohan ml. J Clin Oncol. 2013 Jun 1;31(16):2024-8. doi: 10.1200/JCO.2012.46.5476. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569312 Free PMC article. Clinical Trial.
High-risk features in radiation-associated breast angiosarcomas.
D'Angelo SP, Antonescu CR, Kuk D, Qin L, Moraco N, Carvajal RC, Chi P, Dickson MA, Gounder M, Keohan ML, Singer S, Schwartz GK, Tap WD. D'Angelo SP, et al. Among authors: keohan ml. Br J Cancer. 2013 Oct 29;109(9):2340-6. doi: 10.1038/bjc.2013.590. Epub 2013 Oct 8. Br J Cancer. 2013. PMID: 24104962 Free PMC article.
79 results